We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
-0.46%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$1.75B
AUM Growth
+$42M
(+2.5%)
Cap. Flow
+$91.8M
Cap. Flow
% of AUM
5.25%
Top 10 Holdings %
Top 10 Hldgs %
13.67%
Holding
2,058
New
320
Increased
593
Reduced
660
Closed
478
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$94M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$37.8M |
| 3 |
Bausch Health
BHC
|
+$24.6M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$12.8M |
| 5 |
Dollar Tree
DLTR
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$13.3M |
| 2 |
Cognizant
CTSH
|
+$11.7M |
| 3 |
Edwards Lifesciences
EW
|
+$10.6M |
| 4 |
Walt Disney
DIS
|
+$9.52M |
| 5 |
Kinder Morgan
KMI
|
+$8.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.03% |
| 2 | Technology | 14.96% |
| 3 | Healthcare | 11.13% |
| 4 | Industrials | 8.81% |
| 5 | Financials | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1501
DELISTED
Array Biopharma Inc
ARRY
| $34K | ﹤0.01% |
+11,531
| New | +$34.5K |
|
1502
Sunrun
RUN
$2.51B
| $33K | ﹤0.01% |
5,050
-967
| -16% | -$6.95K |
|
|
EMBJ
1503
Embraer S.A. ADS
EMBJ
$12.9B
| $32K | ﹤0.01% |
1,207
-37,126
| -97% | -$1.02M |
|
|
EVRI
1504
DELISTED
Everi Holdings
EVRI
| $32K | ﹤0.01% |
+14,003
| New | +$42K |
|
|
GEN
1505
DELISTED
Genesis Healthcare, Inc.
GEN
| $32K | ﹤0.01% |
+13,957
| New | +$31.6K |
|
|
SCAI
1506
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $32K | ﹤0.01% |
681
-3,798
| -85% | -$159K |
|
1507
3D Systems Corp
DDD
$599M
| $31K | ﹤0.01% |
2,035
-39,606
| -95% | -$408K |
|
|
ARLZ
1508
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $31K | ﹤0.01% |
+8,758
| New | +$45.1K |
|
1509
Pilgrim's Pride
PPC
$6.3B
| $30K | ﹤0.01% |
1,200
-2,842
| -70% | -$66K |
|
|
BNFT
1510
DELISTED
Benefitfocus, Inc.
BNFT
| $30K | ﹤0.01% |
+906
| New | +$27K |
|
|
OSB
1511
DELISTED
Norbord Inc.
OSB
| $30K | ﹤0.01% |
+1,500
| New | +$27.4K |
|
1512
Innoviva
INVA
$1.52B
| $29K | ﹤0.01% |
+2,342
| New | +$25.7K |
|
1513
PBF Energy
PBF
$7.44B
| $29K | ﹤0.01% |
870
-31,138
| -97% | -$995K |
|
|
SGNT
1514
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $29K | ﹤0.01% |
2,415
-1,382
| -36% | -$19.4K |
|
1515
LSB Industries
LXU
$706M
| $28K | ﹤0.01% |
2,864
+2,816
| +5,867% | +$16.3K |
|
1516
Rigel Pharmaceuticals
RIGL
$735M
| $28K | ﹤0.01% |
+1,350
| New | +$33.3K |
|
|
CJES
1517
DELISTED
C&J ENERGY SVCS LTD
CJES
| $28K | ﹤0.01% |
19,623
-58,525
| -75% | -$124K |
|
1518
Nektar Therapeutics
NKTR
$2.45B
| $27K | ﹤0.01% |
132
-2,568
| -95% | -$493K |
|
|
NAV
1519
DELISTED
Navistar International
NAV
| $26K | ﹤0.01% |
2,039
-10,736
| -84% | -$97.9K |
|
1520
Akebia Therapeutics
AKBA
$351M
| $23K | ﹤0.01% |
2,605
-24,916
| -91% | -$202K |
|
|
ALDR
1521
DELISTED
Alder Biopharmaceuticals
ALDR
| $23K | ﹤0.01% |
952
-1,190
| -56% | -$27.6K |
|
|
ILG
1522
DELISTED
ILG, Inc Common Stock
ILG
| $23K | ﹤0.01% |
+1,593
| New | +$20.6K |
|
|
ALJ
1523
DELISTED
Alon USA Energy Inc
ALJ
| $23K | ﹤0.01% |
2,254
-33,443
| -94% | -$378K |
|
|
AXIA
1524
AXIA Energia
AXIA
$24B
| $21K | ﹤0.01% |
14,627
-8,652
| -37% | -$10.3K |
|
1525
Regal Rexnord
RRX
$12.4B
| $21K | ﹤0.01% |
334
-202
| -38% | -$11.3K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2016 Portfolio in Review
As of Q1 2016, Cubist Systematic Strategies held 2,058 positions worth $1.75B, up 2.5% from $1.71B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Cubist Systematic Strategies deployed $91.8M of net new capital in Q1 2016, opening 320 new positions and adding to 593 existing holdings. Its largest new stake was Arista Networks: 1,116,048 shares worth $4.4M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.3M trimmed.
- Cubist Systematic Strategies's largest Q1 2016 buy was Arista Networks: 1,116,048 shares worth $4.4M.
- Cubist Systematic Strategies added most to State Street SPDR S&P 500 ETF Trust in Q1 2016, an estimated $94M increase.
- Cubist Systematic Strategies's biggest Q1 2016 reduction was Meta Platforms (Facebook), cutting an estimated $13.3M.
- Cubist Systematic Strategies fully exited Visteon in Q1 2016, selling an estimated $5.2M.
- Cubist Systematic Strategies's ten largest holdings make up 14% of its $1.75B portfolio in Q1 2016.
- Cubist Systematic Strategies opened 320 new positions and closed 478 in Q1 2016.
- Cubist Systematic Strategies's portfolio value rose 2.5% quarter-over-quarter to $1.75B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2016, filed 16 May 2016.